University of Pennsylvania
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of Pennsylvania
In tandem with buying the rest of Kleo, Tonix licenses molecular degradation technology from Yale. Neurogene, University of Dundee partner on cell therapies for neurological disorders.
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
A review of biopharma start-up dealmaking and financing activity from January through March 2020, based on data from Biomedtracker.
Public Company Edition: The gene therapy firm’s IPO priced at $18 and ended its first day up 23.3% at $22.20 but fell to $21.50 when stocks recovered on 2 March. Also, RedHill raised $115m for product launches and Movantik purchase, and Avadel raised $65m to compete with Jazz.
- Academic and Research Institutions